12,080.85-45.05
Stock Analysis, IPO, Mutual Funds, Bonds & More

Buy Aurobindo Pharma, price target Rs 515: Manas Jaiswal

The analyst suggested a stoploss at Rs 484.

ETMarkets.com|
Last Updated: Jan 22, 2020, 09.24 AM IST
0Comments
Shutterstock.com
shutterstock_197241950
Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 28889.70 Crore) operating in Pharmaceuticals sector.
Manas Jaiswal of manasjaiswal.com has a buy call on Aurobindo Pharma Ltd. with a target price of Rs 515.0 . The current price of Aurobindo Pharma Ltd. is Rs 503.4 . Manas Jaiswal recommended to keep a stoploss at Rs 484 .

Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 28889.70 Crore) operating in Pharmaceuticals sector.

Aurobindo Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 11922.63 Crore to Sales Value (97.26 % of Total Sales), Pharmaceuticals which contributed Rs 11922.63 Crore to Sales Value (97.26 % of Total Sales), Pharmaceuticals which contributed Rs 11922.63 Crore to Sales Value (97.26 % of Total Sales), Export Incentives which contributed Rs 303.72 Crore to Sales Value (2.47 % of Total Sales), Export Incentives which contributed Rs 303.72 Crore to Sales Value (2.47 % of Total Sales), Export Incentives which contributed Rs 303.72 Crore to Sales Value (2.47 % of Total Sales), Sale of services which contributed Rs 16.07 Crore to Sales Value (0.13 % of Total Sales), Sale of services which contributed Rs 16.07 Crore to Sales Value (0.13 % of Total Sales), Sale of services which contributed Rs 16.07 Crore to Sales Value (0.13 % of Total Sales), Scrap which contributed Rs 15.47 Crore to Sales Value (0.12 % of Total Sales), Scrap which contributed Rs 15.47 Crore to Sales Value (0.12 % of Total Sales) and Scrap which contributed Rs 15.47 Crore to Sales Value (0.12 % of Total Sales)for the year ending 31-Mar-2019.

For the quarter ended 30-09-2019, the company has reported a Consolidated sales of Rs 5518.27 Crore, unchanged .00 % from last quarter Sales of Rs Crore and unchanged .00 % from last year same quarter Sales of Rs Crore Company has reported net profit after tax of Rs 639.46 Crore in latest quarter.

The company’s top management includes Dr.M Sivakumaran, Mr.P V Ramprasad Reddy, Mr.P Sarath Chandra Reddy, Mr.N Govindarajan, Mr.M Sitarama Murthy, Mr.M Madan Mohan Reddy, Mr.K Ragunathan, Mr.K Nithyananda Reddy, Dr.(Mrs.)Avnit Bimal Singh, Mrs.Savita Mahajan. Company has BSR & Associates LLP as its auditoRs As on 31-12-2019, the company has a total of 585,938,609 shares outstanding.

Also Read

Buy United Spirits, price target Rs 765: Manas Jaiswal

Buy Sun TV Network, price target Rs 535: Manas Jaiswal

Buy Balkrishna Industries, price target Rs 1,200: Manas Jaiswal

Buy GAIL (India), price target Rs 139: Manas Jaiswal

Buy Ashok Leyland, price target Rs 90: Manas Jaiswal

Comments
Add Your Comments
Commenting feature is disabled in your country/region.

Other useful Links


Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service